To carry out this responsibility, MHI
has invested deeply in research and development.
The US-APWR is the right technology, MHI
is the right partner and this joint development is the right commercial focus for our team," said Mike Blevins, Luminant executive vice president and chief nuclear officer.
ATMEA was formed as a joint venture between MHI
and AREVA NP to develop the next-generation ATMEA1 reactor.
A signing ceremony held on October 26 in Singapore was attended by officials of the Singapore government and Embassy of Japan and representatives of other concerned parties, including Masagos Zulkifli, Minister of Environment and Water Resources; Ronnie Tay, CEO of NEA; Haruhisa Takeuchi, Ambassador Extraordinary and Plenipotentiary, the Embassy of Japan in Singapore; Olivia Lum, CEO of Hyflux; and Kazuaki Kimura, Board Member & Executive Vice President of MHI
and President & CEO of MHI
's Machinery, Equipment & Infrastructure business.
will be capitalized at approximately 600 million bahts, with EGAT, MHI
, Mitsubishi Corporation and Ratchaburi Electricity Generating Holding PCL owning shares.
's demanding requirement to capture RGB graphics at extremely high rates led MHI
to choose Concurrent technology for its real-time processing capabilities, open architecture design and reliability in meeting tight deployment schedules.
This track record has made MHI
the definitive global leader in commercial applications for CO2 capture plants.
plans to gradually shift part of its flap assembly work for the 737 to an overseas production plant.
Kobe completely migrated to 3D design when they launched a joint development project with Wartsila Switzerland Ltd.
will establish and continue to support the scholarship program for Vietnamese students recommended by MOET to support their studies at universities in Japan.
Based on the KARI's request in 2007, MHI
has proposed a launch services for KOMPSAT-3 by the H-IIA, and in October 2008, MHI
has been selected by KARI as the Successful Bidder for the launch services provider (LSP).
Adrian Almquist, MD, who has been with MHI
since 1988 and specializes in cardiac electrophysiology and pacing, arrhythmias, hypertrophic cardiomyopathy, syncope/fainting, autonomic dysfunction and heart rhythm management